Institutional investors purchased a net $9.6 million shares of FOLD during the quarter ended December 2016 and now own 110.16% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
APO ASSET MANAGEMENT GMBH Bought 71.6 Thousand shares of Amicus Therapeutics Inc